Recurrence · participants with confirmed toenail onychomycosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · participants with confirmed toenail onychomycosis
Azole showed no clear difference in adverse events compared with terbinafine (moderate certainty).
1 finding from 1 review
Quality of life · participants with confirmed toenail onychomycosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence · participants with confirmed toenail onychomycosis
Azole showed no clear difference in recurrence rate compared with terbinafine (low certainty).
1 finding from 1 review
Quality of life · participants with confirmed toenail onychomycosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical cure · participants with confirmed toenail onychomycosis
Terbinafine leads to higher clinical cure compared with placebo (high certainty).
1 finding from 1 review
Mycological cure · participants with confirmed toenail onychomycosis
Terbinafine leads to higher mycological cure compared with placebo (high certainty).
1 finding from 1 review
Adverse events · participants with confirmed toenail onychomycosis
Terbinafine showed no clear difference in adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Recurrence · participants with confirmed toenail onychomycosis
Terbinafine may leads to lower recurrence rate compared with placebo (low certainty).
1 finding from 1 review
Change from baseline in disease severity according to participants ‐ not measured · people with eczema
The review found no eligible studies for this question.
1 finding from 1 review
Number of participants reporting an adverse event · people with eczema
Atopiclair showed no clear difference in number of participants reporting an adverse event compared with vehicle (moderate certainty).
1 finding from 1 review
Change from baseline in disease severity as assessed by the investigators · people with eczema
1 finding from 1 review
Number of participants who experienced a flare · people with eczema
Atopiclair probably leads to lower number of participants who experienced a flare compared with vehicle (moderate certainty).
1 finding from 1 review
Change in use of topical active treatment ‐ not measured · people with eczema
The review found no eligible studies for this question.
1 finding from 1 review
Change from baseline in health‐related quality of life ‐ not measured · people with eczema
The review found no eligible studies for this question.
1 finding from 1 review
Change from baseline in disease severity as assessed by the participants (number of participants who considered their skin to have improved) · people with eczema
Urea‐containing moisturisers may leads to higher change from baseline in disease severity according to the… compared with vehicle, placebo or no moisturiser (low certainty).
1 finding from 1 review
Participant satisfaction · people with eczema
1 finding from 1 review
Number of participants reporting an adverse event · people with eczema
Urea‐containing moisturisers probably leads to higher number of participants reporting an adverse event compared with vehicle, placebo or no moisturiser (moderate certainty).
1 finding from 1 review
Change from baseline in disease severity according to the investigators (number of participants who improved according to the investigators) · people with eczema
Urea‐containing moisturisers probably leads to higher change from baseline in disease severity according to the… compared with vehicle, placebo or no moisturiser (moderate certainty).
1 finding from 1 review
Number of participants who experienced a flare · people with eczema
Urea‐containing moisturisers may leads to lower number of participants who experienced a flare compared with vehicle, placebo or no moisturiser (low certainty).
1 finding from 1 review